160 related articles for article (PubMed ID: 17670894)
1. Non-transferrin-bound iron reaches mitochondria by a chelator-inaccessible mechanism: biological and clinical implications.
Shvartsman M; Kikkeri R; Shanzer A; Cabantchik ZI
Am J Physiol Cell Physiol; 2007 Oct; 293(4):C1383-94. PubMed ID: 17670894
[TBL] [Abstract][Full Text] [Related]
2. The role of endocytic pathways in cellular uptake of plasma non-transferrin iron.
Sohn YS; Ghoti H; Breuer W; Rachmilewitz E; Attar S; Weiss G; Cabantchik ZI
Haematologica; 2012 May; 97(5):670-8. PubMed ID: 22180428
[TBL] [Abstract][Full Text] [Related]
3. Transferrin-iron routing to the cytosol and mitochondria as studied by live and real-time fluorescence.
Shvartsman M; Fibach E; Cabantchik ZI
Biochem J; 2010 Jul; 429(1):185-93. PubMed ID: 20408812
[TBL] [Abstract][Full Text] [Related]
4. Intracellular labile iron pools as direct targets of iron chelators: a fluorescence study of chelator action in living cells.
Glickstein H; El RB; Shvartsman M; Cabantchik ZI
Blood; 2005 Nov; 106(9):3242-50. PubMed ID: 16020512
[TBL] [Abstract][Full Text] [Related]
5. Iron and oxidative stress in cardiomyopathy in thalassemia.
Berdoukas V; Coates TD; Cabantchik ZI
Free Radic Biol Med; 2015 Nov; 88(Pt A):3-9. PubMed ID: 26216855
[TBL] [Abstract][Full Text] [Related]
6. Chelation of iron within the erythrocytic Plasmodium falciparum parasite by iron chelators.
Loyevsky M; John C; Dickens B; Hu V; Miller JH; Gordeuk VR
Mol Biochem Parasitol; 1999 Jun; 101(1-2):43-59. PubMed ID: 10413042
[TBL] [Abstract][Full Text] [Related]
7. Iron acquired from transferrin by K562 cells is delivered into a cytoplasmic pool of chelatable iron(II).
Breuer W; Epsztejn S; Cabantchik ZI
J Biol Chem; 1995 Oct; 270(41):24209-15. PubMed ID: 7592626
[TBL] [Abstract][Full Text] [Related]
8. Intracellular iron trafficking: role of cytosolic ligands.
Shvartsman M; Ioav Cabantchik Z
Biometals; 2012 Aug; 25(4):711-23. PubMed ID: 22350471
[TBL] [Abstract][Full Text] [Related]
9. Calcein as a fluorescent iron chemosensor for the determination of low molecular weight iron in biological fluids.
Ali A; Zhang Q; Dai J; Huang X
Biometals; 2003 Jun; 16(2):285-93. PubMed ID: 12572687
[TBL] [Abstract][Full Text] [Related]
10. Redistribution of accumulated cell iron: a modality of chelation with therapeutic implications.
Sohn YS; Breuer W; Munnich A; Cabantchik ZI
Blood; 2008 Feb; 111(3):1690-9. PubMed ID: 17975016
[TBL] [Abstract][Full Text] [Related]
11. Modulation by iron loading and chelation of the uptake of non-transferrin-bound iron by human liver cells.
Parkes JG; Randell EW; Olivieri NF; Templeton DM
Biochim Biophys Acta; 1995 Apr; 1243(3):373-80. PubMed ID: 7727512
[TBL] [Abstract][Full Text] [Related]
12. The labile iron pool: characterization, measurement, and participation in cellular processes(1).
Kakhlon O; Cabantchik ZI
Free Radic Biol Med; 2002 Oct; 33(8):1037-46. PubMed ID: 12374615
[TBL] [Abstract][Full Text] [Related]
13. Triphenylphosphonium-desferrioxamine as a candidate mitochondrial iron chelator.
Alta RYP; Vitorino HA; Goswami D; Terêsa Machini M; Espósito BP
Biometals; 2017 Oct; 30(5):709-718. PubMed ID: 28770399
[TBL] [Abstract][Full Text] [Related]
14. Uptake and intracellular distribution of iron from transferrin and chelators in erythroid cells.
Kontoghiorghes GJ; May A
Biol Met; 1990; 3(3-4):183-7. PubMed ID: 2073459
[TBL] [Abstract][Full Text] [Related]
15. Variable inhibitory effects on the formation of dinitrosyl iron complexes by deferoxamine and salicylaldehyde isonicotinoyl hydrazone in K562 cells.
Meczynska S; Lewandowska H; Sochanowicz B; Sadlo J; Kruszewski M
Hemoglobin; 2008; 32(1-2):157-63. PubMed ID: 18274993
[TBL] [Abstract][Full Text] [Related]
16. Residual erythropoiesis protects against myocardial hemosiderosis in transfusion-dependent thalassemia by lowering labile plasma iron via transient generation of apotransferrin.
Garbowski MW; Evans P; Vlachodimitropoulou E; Hider R; Porter JB
Haematologica; 2017 Oct; 102(10):1640-1649. PubMed ID: 28642302
[TBL] [Abstract][Full Text] [Related]
17. Effect of iron chelators on placental uptake and transfer of iron in rat.
Wong CT; McArdle HJ; Morgan EH
Am J Physiol; 1987 May; 252(5 Pt 1):C477-82. PubMed ID: 3578500
[TBL] [Abstract][Full Text] [Related]
18. Action of chelators in iron-loaded cardiac cells: Accessibility to intracellular labile iron and functional consequences.
Glickstein H; El RB; Link G; Breuer W; Konijn AM; Hershko C; Nick H; Cabantchik ZI
Blood; 2006 Nov; 108(9):3195-203. PubMed ID: 16835377
[TBL] [Abstract][Full Text] [Related]
19. Iron uptake by Chang cells from transferrin, nitriloacetate and citrate complexes: the effects of iron-loading and chelation with desferrioxamine.
White GP; Jacobs A
Biochim Biophys Acta; 1978 Oct; 543(2):217-25. PubMed ID: 728460
[TBL] [Abstract][Full Text] [Related]
20. Iron-chelating agents attenuate NMDA-Induced neuronal injury via reduction of oxidative stress in the rat retina.
Sakamoto K; Suzuki T; Takahashi K; Koguchi T; Hirayama T; Mori A; Nakahara T; Nagasawa H; Ishii K
Exp Eye Res; 2018 Jun; 171():30-36. PubMed ID: 29530811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
